Changing the World for Pediatric Fungal Diseases
FEATURED
2026 Annual Report Spotlight
Discover how PFN-STRIDE researchers, clinicians, patients, families, and advocacy partners are working together to advance research, improve diagnosis and treatment, and enhance outcomes for children affected by rare invasive fungal diseases.
PFN-STRIDE Mission Statement
The mission of the PFN-STRIDE consortium is to perform research that yields pediatric-specific data on the epidemiology, diagnosis, treatment, and outcomes of invasive fungal disease.
Find a Clinical Site Near You
Participants make it possible for researchers to find new treatments, speed diagnosis and improve the lives of those affected by rare diseases.
Learn More
RDCRN Publishes First-Ever Annual Report
Read about research consortium achievements, early career investigators, patients and patient advocacy groups, and other network accomplishments.
New Pilot Study Aims to Improve Identification of Pediatric Invasive Mold Infections in Immunocompromised Children
A new pilot study led by William Otto, MD, aims to use EHR-based algorithms to improve identification of pediatric invasive mold infections in immunocompromised children.
